A colistin adjuvant valnemulin is identified to circumvent MDR bacterial pathogens and treat recalcitrant infections by causing membrane permeabilization, proton motive force dissipation, and reduction in intracellular ATP level.
- Chen Xu
- Yuan Zhang
- Ning Dong
